Using core public health functions to promote BRCA best practices among health plans
- PMID: 22189434
- DOI: 10.1159/000334267
Using core public health functions to promote BRCA best practices among health plans
Abstract
Objective: The Michigan Department of Community Health (MDCH) Cancer Genomics Program sought to increase the number of health plans with a written policy aligned with the United States Preventive Services Task Force (USPSTF) Grade B Recommendation stating that women whose family history is associated with an increased risk for deleterious mutations in BRCA1 or BRCA2 be referred for genetic counseling and evaluation for BRCA testing.
Methods: Through a cooperative agreement with the Centers for Disease Control and Prevention, MDCH with health plan partners utilized multiple methods (i.e. surveillance, education, federal and state policies, partnerships, and dissemination) to increase the number of health plans with a written policy aligned with the USPSTF Grade B BRCA Recommendation between 2008 and 2011.
Results: Since 2008, the number of health plans that have policies consistent with USPSTF Grade B BRCA Recommendation in Michigan increased from 4 to 11. These 11 health plans provide coverage to over 7 million Michigan residents. Honors were bestowed by MDCH to these 11 health plans for their exemplary written policies.
Conclusions: MDCH has implemented a novel and effective approach to promote cancer genomics best practices through health plan policies that serves as a model for federal and state agencies.
Copyright © 2011 S. Karger AG, Basel.
Similar articles
-
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.Cancer. 2006 Dec 15;107(12):2745-51. doi: 10.1002/cncr.22352. Cancer. 2006. PMID: 17109443
-
Health plan implementation of U.S. Preventive Services Task Force A and B recommendations--Colorado, 2010.MMWR Morb Mortal Wkly Rep. 2011 Oct 7;60(39):1348-50. MMWR Morb Mortal Wkly Rep. 2011. PMID: 21976117
-
BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling.Cancer Treat Rev. 2001 Oct;27(5):295-304. doi: 10.1053/ctrv.2001.0233. Cancer Treat Rev. 2001. PMID: 11871866 Review.
-
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.Cancer. 2003 Jan 1;97(1):1-11. doi: 10.1002/cncr.11048. Cancer. 2003. PMID: 12491499
-
Breast cancer susceptibility testing: past, present and future.Expert Rev Anticancer Ther. 2006 Aug;6(8):1205-14. doi: 10.1586/14737140.6.8.1205. Expert Rev Anticancer Ther. 2006. PMID: 16925486 Review.
Cited by
-
Medicaid Expansions: Probing Medicaid's Filling of the Cancer Genetic Testing and Screening Space.Healthcare (Basel). 2022 Jun 8;10(6):1066. doi: 10.3390/healthcare10061066. Healthcare (Basel). 2022. PMID: 35742117 Free PMC article. Review.
-
Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.Public Health Genomics. 2020;23(5-6):218-229. doi: 10.1159/000510336. Epub 2020 Sep 17. Public Health Genomics. 2020. PMID: 32942283 Free PMC article.
-
Blending Insights from Implementation Science and the Social Sciences to Mitigate Inequities in Screening for Hereditary Cancer Syndromes.Int J Environ Res Public Health. 2019 Oct 15;16(20):3899. doi: 10.3390/ijerph16203899. Int J Environ Res Public Health. 2019. PMID: 31618814 Free PMC article.
-
The strategic defense of physician autonomy: State public health agencies as countervailing powers.Soc Sci Med. 2017 Aug;186:113-121. doi: 10.1016/j.socscimed.2017.06.007. Epub 2017 Jun 3. Soc Sci Med. 2017. PMID: 28622609 Free PMC article.
-
Exploring barriers to payer utilization of genetic counselors.J Genet Couns. 2015 Feb;24(1):122-33. doi: 10.1007/s10897-014-9745-0. Epub 2014 Aug 20. J Genet Couns. 2015. PMID: 25138080
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
